Physician profile
Emily Mayer
NPI 1598394694
$3,413.40
in general payments reported to CMS, 2019-2025
18 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2022: $619 · 2023: $959 · 2024: $627 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,627.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,675.38 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $360.52 | 2022-2025 | Caplyta |
| Axsome Therapeutics, INC. | $284.37 | 2024-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $215.97 | 2022-2025 | Ingrezza |
| Lundbeck LLC | $124.08 | 2023-2025 | Rexulti |
| Corium, LLC | $124.04 | 2023 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $112.96 | 2022-2024 | Rexulti |
| Supernus Pharmaceuticals, INC. | $90.65 | 2022-2025 | Qelbree |
| Neos Therapeutics, LP | $66.12 | 2024-2025 | Adzenys Xr-Odt |
| Takeda Pharmaceuticals U.S.A., INC. | $64.89 | 2024-2025 | Trintellix |
| Vanda Pharmaceuticals INC. | $63.86 | 2025 | Fanapt |
| Janssen Pharmaceuticals, INC | $55.05 | 2025 | Spravato |
| Ironshore Pharmaceuticals INC. | $51.72 | 2024 | |
| Alkermes, INC. | $41.41 | 2025 | Lybalvi |
| Tms Neurohealth Centers INC. | $23.58 | 2025 | Tms Neurohealth Centers INC. |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $22.80 | 2025 | Cobenfy |
| Collegium Pharmaceutical, INC. | $19.94 | 2025 | Jornay Pm |
| Bausch Health US, LLC | $16.06 | 2025 | Aplenzin, Wellbutrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Mayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.